MCE 的所有產品僅用作科學研究或藥證申報，我們不為任何個人用途提供產品和服務。

(R)-BPO-27

CAS No. : 1415390-47-4

產品活性：(R)-BPO-27, the R enantiomer of BPO-27, is a potent, orally active and ATP-competitive CFTR?inhibitor with an?IC₅₀ of 4 nM.

研究領域：Membrane Transporter/Ion Channel  |  Autophagy

作用靶點：CFTR  |  Autophagy

In Vitro: (R)-BPO-27 exhibits a dose-response inhibition and inhibits the CFTR current by 50% at 0.53 nM in HEK-293T cells. (R)-BPO-27 acts from the cytoplasmic side and has low membrane permeability.
(R)-BPO-27 reduces the channel open probability (NPo) from 0.29 to 0.08, modestly reduces in mean channel open time, and strongly increases mean channel closed time in HEK-293T cells expressing human wild-type CFT in a single-channel patch-clamp experiment. Meanwhile, (S)-BPO-27 does not affect any of these parameters.
(R)-BPO-27 is applied directly to the cytoplasmic membrane surface and stabilizes the CFTR channel closed state with an IC₅₀ of 600 pM in Single-channel electrophysiology assay.
(R)-BPO-27 (10 μM, 10 min pretreatment) inhibits Cl^-?current with apparent IC₅₀?values of 5 and 10 nM for CPT-cAMP and 8-Br-cGMP, respectively, in CFTR-expressing FRT cells after CFTR stimulation by cAMP agonist. the IC₅₀ of 4 nM for inhibition of forskolin-stimulated CFTR Cl^-?current in FRT cells.

In Vivo: (R)-BPO-27 (interperitoneal administration; 10 mg/kg)?decays with t_1/2≈1.6 h and gives sustained therapeutic concentrations in kidney in a PK study.
(R)-BPO-27 (intraperitoneal injection; 5 mg/kg; 30 min before abdominal surgery) prevents fluid accumulation in closed midjejunal loops produced by cholera toxin, giving an intestinal loop weight/length ratio similar to that in PBS-injected loops. This effect is dose-dependently and the IC₅₀ value is 0.1 mg/kg.
(R)-BPO-27 (intraperitoneal injection or oral administration; 5 mg/kg) shows a slow (R)-BPO-27 metabolism and produces sustained serum (R)-BPO-27 levels for at least 4 h. The AUC analysis gave an oral bioavailability of ～94% for (R)-BPO-27 in mouse pharmacokinetics and toxicity study.

相關產品：Bioactive Compound Library Plus  |  PG01  |  SRI-41315  |  Nesolicaftor  |  (R)-Posenacaftor sodium  |  GlyH-101  |  Bamocaftor  |  CFTR activator 1  |  CP-628006  |  Ivacaftor-d₉  |  Aloisine A  |  K41498 TFA  |  GLPG1837  |  (Rac)-Tezacaftor  |  Vanzacaftor  |  Icenticaftor  |  (R)-Olacaftor  |  Galicaftor  |  Posenacaftor  |  Urocortin III (mouse) (free acid)  |  Elexacaftor  |  Crinecerfont hydrochloride  |  CFTR corrector 2  |  CFTR corrector 6  |  SRI-37240  |  GLPG-3221  |  Kobusin  |  CFTR corrector 9

熱門產品線：重組蛋白  |  化合物庫  |  天然產物  |  熒光染料  |  PROTAC  |  同位素標記物  |  寡核苷酸  |  抗體  |  點擊化學

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

品牌介紹:
•   MCE (MedChemExpress) 擁有200 多種*僅有化合物庫，我們致力于為*科研客戶提供前沿的高品質小分子活性化合物；
•   50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領；
•   產品種類涵蓋各種重組蛋白，多肽，常用試劑盒 ，更有 PROTAC、ADC 等特色產品，廣泛應用于新藥研發、生命科學等科研項目；
•   提供虛擬篩選，離子通道篩選，代謝組學分析檢測分析，藥物篩選等專業技術服務；
•   設有專業的實驗中心和嚴格的質控、驗證體系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質檢報告，確保產品的高純度、高品質；
•   產品的生物活性多經各國客戶實驗驗證；
•   Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果；
•   專業團隊跟蹤新的制藥及生命科學研究進展，為您提供*新的活性化合物；
•   與世界各大制藥公司及*科研機構建立了長期的合作。